According to the latest report by IMARC Group, titled, “Orthobiologics Market Size: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, the global orthobiologics market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026.
Orthobiologics refer to tissue-derived products manufactured by utilizing naturally found substances in the body, such as carbohydrates, proteins, cells, glycoproteins, etc. Some of the widely used orthobiologic therapies include stem cells, platelet-rich plasma (PRP), autologous conditioned plasma (ACP), bone marrow aspirate concentrate (BMAC), etc. They aid in minimizing pain and inflammation, reversing debilitating effects of osteoarthritis, facilitating cartilage regeneration, etc. Orthobiologics also help in the speedy recovery of sports-related injuries among professional and recreational athletes.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Orthobiologics Market Trends:
The growing participation of individuals in physical activities is augmenting the need for orthobiologics to treat numerous sports-related injuries, such rotator cuff tears, shoulder osteoarthritis, knee osteoarthritis, etc. Additionally, the rising geriatric population, who are more prone to age-related osteoporosis, is also propelling the product demand. Besides this, the increasing risk of developing osteoarthritis due to sedentary lifestyles and unhealthy dietary patterns is further catalyzing the global market. Apart from this, the growing need for minimally-invasive orthopedic surgeries and the escalating demand for bioabsorbable implants are further anticipated to fuel the orthobiologic market over the forecasted period.
Request a Free Sample Report: https://www.imarcgroup.com/orthobiologics-market/requestsample
Orthobiologics Market 2021-2026 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Arthrex Inc, Globus Medical Inc., Integra LifeSciences, Johnson & Johnson, Medline Industries Inc., Medtronic plc, NuVasive Inc, Orthofix Medical Inc., Smith & Nephew plc, Stryker Corporation, Terumo Corporation, Wright Medical Group N.V. and Zimmer Biomet.
The report has segmented the market on the basis on product, type, application and end user.
Breakup by Product:
- Demineralized Bone Matrix
- Bone Morphogenetic Protein
- Viscosupplementation Products
- Synthetic Bone Substitutes
Breakup by Type:
- Wrist and Shoulder
Breakup by Application:
- Osteoarthritis and Degenerative Arthritis
- Spinal Fusion
- Fracture Recovery
- Soft Tissue Injuries
- Maxillofacial and Dental Applications
Breakup by End User:
- Hospitals and Ambulatory Centers
- Research and Academic Institutes
- Dental Clinics and Facilities
- Orthopedic Clinics
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/orthobiologics-market
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800